Timing-Dependent Phage-Antibiotic Effects on the Survival of the Non-Target Bacillus subtilis in an Escherichia coli Co-Culture
ISEF · 2026 Biomedical and Health Sciences
Overview
Purpose: Antibiotic resistance is growing. Bacteriophages (phages) are viruses that infect bacteria; using phages and antibiotics together has a synergistic effect. This study applied phages and antibiotics in different orders to determine which has greatest reduction of non-target Bacillus subtilis species in an Escherichia coli co-culture. Procedure: B. subtilis and E. coli were incubated on LB agar for 24 hours. Bacteria were harvested with isotonic buffer at 10^6 CFU/ml, confirmed via spectrophotometry. A concentration causing ~42.8% inhibition in E. coli for the Aztreonam antibiotic and a MOI of 0.7 (yielding ~50% inhibiton) for the T4 phage was chosen. After the bacterial solution was plated on LB agar via spread plate, T4 and Aztreonam were applied in three orders: Phage first (P, A), Antibiotic first (A,P), and Simultaneous addition (SA), with 1 hour gap in sequential treatments. Aliquots were plated on selective agar at 0, 1, 3, and 6 hours. Results: Kruskall-Wallis tests showed significant differences in treatment groups (p<0.01). The A,P group had the most statistically significant reduction in E. coli, and both the A,P and SA groups had the most reduction in B. subtilis. Aztreonam possibly caused E. coli to elongate (filamentation), allowing phages to produce more offspring per infection. This resulted in a 1.9x advantage for virus in filamented cells (based on Berg-Purcell capacitance equation with dimensions based on microscopy). An inverse correlation between E. coli lysis and B. subtilis survival (p<0.001) suggested a bystander effect. Biophysical modeling was utilized alongside proposed mechanisms. Conclusion: The results showed that A,P had the most reduction in microbial load (57.50%), in comparison to the P,A (36.61%) and SA (45.55%) groups.
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2019
Turning Over a New Phage: A Novel Approach to Phage Therapy
ISEF · 2020
Instrumentation & Investigation of Phage-Antibiotic Synergy on K. pneumoniae, H. alvei, and Transductant H. alvei
ISEF · 2019
Viruses to the Rescue?: Using Microtiter Assays and an In-Lab Developed Simulated Anatomic Lung Model to Determine the Effectiveness of Bacteriophage Therapy as a Preventative Measure against Poly-Microbial Biofilms in Cystic Fibrosis Patients
ISEF · 2014
The Inception of Infection II: The Antimicrobial and Synergistic Efficiency of Antibiotic Ethambutol and Isoniazid and Bacteriophage D29 in Treating a Model Organism for Tuberculosis
ISEF · 2015
Comparative Analysis of Bacteriophages, Natural Antibacterials and Pharmaceutical Antibiotics Against Escherichia coli, Bacillus cereus and Enterobacter aerogenes
ISEF · 2018
Viruses to the Rescue: Using D. tsuruhatensis to Demonstrate Phage Therapy's Effectiveness Against Antibiotic Resistant Bacterial Biofilms in a Medical Setting
ISEF · 2023
Turning the Phage: Effects of Bacteriophages on E. coli K12
ISEF · 2015
Developing an Effective Phage Therapy for Treatment of Methicillin-Resistant Staphylococcus aureus
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair